Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integral radiation dose to normal structures with conformal external beam radiation.

Hidefumi Aoyama1, David Clark Westerly, Thomas Rockwell Mackie

  • 1Department of Human Oncology, University of Wisconsin, Madison, WI, USA. hao@radi.med.hokudai.ac.jp

International Journal of Radiation Oncology, Biology, Physics
|February 7, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the efficacy of plan adaptation in stereotactic body proton therapy for pancreatic cancer.

Journal of applied clinical medical physics·2026
Same author

Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective study.

Journal of radiation research·2026
Same author

Therapeutic Courses of Presumed Intracranial Immature Teratoma Diagnosed Based on Increased Alpha-Fetoprotein.

Journal of child neurology·2026
Same author

Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM).

Breast cancer (Tokyo, Japan)·2026
Same author

Feasibility Study of Multiorgan Dosiomics for Evaluating Radiation-Induced Xerostomia and Dysphagia in Head and Neck Cancer Radiotherapy.

Cancers·2026
Same author

Prospective Registry and Meta-Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real-World Impact.

Cancer medicine·2026

Intensity-modulated radiotherapy (IMRT) for prostate cancer shows minimal normal tissue integral dose (NTID) differences compared to 3D conformal radiotherapy (3DCRT). Tomotherapy IMRT offers superior dose sparing for critical structures like the rectal wall and penile bulb.

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Cancer Treatment

Background:

  • Evaluating normal tissue integral dose (NTID) from intensity-modulated radiotherapy (IMRT) is crucial for prostate cancer treatment optimization.
  • Understanding dose distribution differences between various radiotherapy techniques is essential for minimizing side effects.

Purpose of the Study:

  • To compare the integral dose (ID) received by normal tissues in patients with localized prostate cancer using different radiotherapy techniques.
  • To assess the effectiveness of intensity-modulated radiotherapy (IMRT) with varying energy levels and tomotherapy in reducing normal tissue dose.

Main Methods:

  • Generated 25 radiation treatment plans for 5 prostate cancer patients, including 6 MV and 20 MV IMRT, 6 MV and 20 MV 3D conformal radiotherapy (3DCRT), and 6 MV tomotherapy IMRT (Tomo-IMRT).

Related Experiment Videos

  • Calculated normal tissue integral dose (NTID) using dose-volume histograms for each treatment plan.

    • Main Results:

    • 6 MV IMRT reduced NTID by 5.0% compared to 6 MV 3DCRT. 20 MV plans showed a 7.7%-11.2% NTID reduction versus 6 MV 3DCRT.
    • Tomo-IMRT demonstrated comparable NTID to 6 MV IMRT but significantly reduced doses to the rectal wall (11.9%) and penile bulb (16.5%) compared to 6 MV 3DCRT.
    • 20 MV plans did not show additional dose reduction benefits for the rectal wall and penile bulb compared to 6 MV plans.

    Conclusions:

    • The overall NTID difference between 3DCRT and IMRT is minor, with 20 MV plans offering a slight NTID reduction over 6 MV plans.
    • Tomo-IMRT provides a significant advantage in sparing the rectal wall and penile bulb for localized prostate cancer patients compared to conventional IMRT and 3DCRT.
    • The study highlights tomotherapy's potential for improved treatment outcomes by minimizing dose to organs at risk.